Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123951272 | 12395127 | 2 | F | 20130626 | 20160922 | 20160523 | 20160927 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-31743BI | BOEHRINGER INGELHEIM | 76.73 | YR | F | Y | 0.00000 | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123951272 | 12395127 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 123951272 | 12395127 | 2 | C | AVAPRO | IRBESARTAN | 1 | Oral | 300 MG | 0 | 300 | MG | TABLET | QD | ||||||
| 123951272 | 12395127 | 3 | C | PROVENTIL | ALBUTEROL | 1 | Respiratory (inhalation) | 9 ML | 0 | 3 | ML | INHALATION SOLUTION | TID | ||||||
| 123951272 | 12395127 | 4 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | 1.5 MG | 0 | .5 | MG | INHALATION SOLUTION | Q8H | ||||||
| 123951272 | 12395127 | 5 | C | CRANBERRY. | CRANBERRY | 1 | Oral | 500 MG | 0 | 500 | MG | CAPSULE | QD | ||||||
| 123951272 | 12395127 | 6 | C | KRILL OIL-OMEGA-3-DHA-EPA | 2 | Oral | 1 ANZ | 0 | CAPSULE | QD | |||||||||
| 123951272 | 12395127 | 7 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Other | 100 MCG | 0 | 50 | UG | ORAL SUSPENSION | |||||||
| 123951272 | 12395127 | 8 | C | OPTIVAR | AZELASTINE HYDROCHLORIDE | 1 | Intraocular | STRENGTH: 0.5%, 1 DROP BY BOTH EYES ROUTE TWICE PER DAY AS NEEDED | 0 | EYE DROPS | BID | ||||||||
| 123951272 | 12395127 | 9 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | Respiratory (inhalation) | 2 PUF | 0 | NEBULISER LIQUID | BID | ||||||||
| 123951272 | 12395127 | 10 | C | HYGROTEN | 2 | Oral | 25 MG | 0 | 25 | MG | TABLET | QD | |||||||
| 123951272 | 12395127 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 5000 U | 0 | 5000 | IU | TABLET | QD | ||||||
| 123951272 | 12395127 | 12 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 100 MG | 0 | 100 | MG | CAPSULE | QD | ||||||
| 123951272 | 12395127 | 13 | C | SUPER B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | 1 ANZ | 0 | TABLET | QD | ||||||||
| 123951272 | 12395127 | 14 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 123951272 | 12395127 | 15 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 123951272 | 12395127 | 16 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 123951272 | 12395127 | 17 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | 8 MG | 0 | 4 | MG | TABLET | BID | ||||||
| 123951272 | 12395127 | 18 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
| 123951272 | 12395127 | 19 | C | VYTORIN 10/20 | 2 | Oral | STRENGTH: 10-20MG; 1/2 TABLET EVERY OTHER DAY QPM | 0 | TABLET | QOD | |||||||||
| 123951272 | 12395127 | 20 | C | VYTORIN 10/20 | 2 | Oral | STRENGTH: 10-20MG;1/2 TABLET EVERY OTHER DAY. | 0 | TABLET | QOD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123951272 | 12395127 | 1 | Atrial fibrillation |
| 123951272 | 12395127 | 2 | Product used for unknown indication |
| 123951272 | 12395127 | 3 | Wheezing |
| 123951272 | 12395127 | 4 | Product used for unknown indication |
| 123951272 | 12395127 | 5 | Product used for unknown indication |
| 123951272 | 12395127 | 6 | Product used for unknown indication |
| 123951272 | 12395127 | 7 | Product used for unknown indication |
| 123951272 | 12395127 | 8 | Product used for unknown indication |
| 123951272 | 12395127 | 9 | Product used for unknown indication |
| 123951272 | 12395127 | 10 | Product used for unknown indication |
| 123951272 | 12395127 | 11 | Product used for unknown indication |
| 123951272 | 12395127 | 12 | Product used for unknown indication |
| 123951272 | 12395127 | 13 | Product used for unknown indication |
| 123951272 | 12395127 | 14 | Product used for unknown indication |
| 123951272 | 12395127 | 15 | Product used for unknown indication |
| 123951272 | 12395127 | 16 | Product used for unknown indication |
| 123951272 | 12395127 | 17 | Product used for unknown indication |
| 123951272 | 12395127 | 18 | Product used for unknown indication |
| 123951272 | 12395127 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123951272 | 12395127 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123951272 | 12395127 | Cerebral haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123951272 | 12395127 | 1 | 20130404 | 0 |